Pharmacokinetic Study of Solamargine in Patients With Actinic Keratosis
Status:
Completed
Trial end date:
2014-02-01
Target enrollment:
Participant gender:
Summary
This study is designed to evaluate the pharmacokinetics of solamargine of SR-T100 gel. As
safety parameters, adverse events, and vital signs (blood pressure, heart rate, and body
temperature) will be recorded.